Neurological Institute Outcomes
Insomnia is a common sleep disorder, characterized by the inability to initiate or maintain sleep or early morning awakening despite the opportunity to sleep. At least one-third of the adult population reports having symptoms consistent with insomnia, and 10% to 15% meet the diagnostic criteria for chronic insomnia. Untreated insomnia is associated with many psychiatric and medical comorbidities, in addition to a significant economic burden related to increased healthcare utilization, decreased productivity, and absenteeism. Cognitive behavioral therapy for insomnia (CBT-I), which does not involve sedative-hypnotic medications, is one of the most effective treatments for insomnia.
Patients are evaluated and treated for insomnia with CBT-I by a behavioral sleep medicine expert at the Sleep Disorders Center, individually or in a group setting. CBT-I strategies include stimulus control, sleep restriction, and cognitive restructuring of negative thoughts about sleep. Meta-analyses have shown better and more durable outcomes in insomnia patients using CBT-I compared with using sedative-hypnotic medications alone.
Improvement in Insomnia-Related Symptoms Following Individual CBT-I
2018 – 2019
CBT-I = cognitive behavioral therapy for insomnia, ESS = Epworth Sleepiness Scale, FSS = Fatigue Severity Scale, ISI = Insomnia Severity Index, PHQ-9 = Patient Health Questionnaire, PROMIS = Patient-Reported Outcomes Measurement Information System, TST = total sleep time